Cost-effectiveness of Population-Wide Genomic Screening for Hereditary Breast and Ovarian Cancer in the United States

IMPORTANCE: Genomic screening for hereditary breast and ovarian cancer (HBOC) in unselected women offers an opportunity to prevent cancer morbidity and mortality, but the potential clinical impact and cost-effectiveness of such screening have not been well studied. OBJECTIVE: To estimate the lifetim...

Descripción completa

Detalles Bibliográficos
Autores principales: Guzauskas, Gregory F., Garbett, Shawn, Zhou, Zilu, Spencer, Scott J., Smith, Hadley S., Hao, Jing, Hassen, Dina, Snyder, Susan R., Graves, John A., Peterson, Josh F., Williams, Marc S., Veenstra, David L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2020
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7596578/
https://www.ncbi.nlm.nih.gov/pubmed/33119106
http://dx.doi.org/10.1001/jamanetworkopen.2020.22874

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7596578/
https://www.ncbi.nlm.nih.gov/pubmed/33119106
http://dx.doi.org/10.1001/jamanetworkopen.2020.22874

Ejemplares similares